Back to top

cell-therapy: Archive

Sundeep Ganoria

3 Under-$10 Drug Stocks Wall Street Analysts Recommend Buying

We present three small biotech stocks, which most analysts on Wall Street are optimistic about. These companies have upside potential for 2023 despite an uncertain macro environment.

ADAPPositive Net Change KMDANegative Net Change ZYMENegative Net Change